Tufts University School of Medicine, Boston (United States of America)
Membership:
EAPC Member
Follow
Contributor content
Presentation
Does early initiation of non-statin therapy, evolocumab with LDL-C <50mg/dL contribute to the reduction of hospital readmissions in patients with ACS?: a single center real world evidence from ELAINE
